Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.

× No keyword cloud information.

44 in total

1. Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro.

Authors: J R Govan; J A Fyfe
Journal: J Antimicrob Chemother Date: 1978-05 Impact factor: 5.790

2. Mucoid variation in Pseudomonas aeruginosa induced by the action of phage.

Authors: D R Martin
Journal: J Med Microbiol Date: 1973-02 Impact factor: 2.472

3. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.

Authors: J D Klinger; D C Straus; C B Hilton; J A Bass
Journal: J Infect Dis Date: 1978-07 Impact factor: 5.226

4. Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.

Authors: M J Thomassen; C A Demko; B Boxerbaum; R C Stern; P J Kuchenbrod
Journal: J Infect Dis Date: 1979-12 Impact factor: 5.226

5. Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum.

Authors: W M McCrae; J A Raeburn; E J Hanson
Journal: J Infect Dis Date: 1976-08 Impact factor: 5.226

6. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin.

Authors: M F Parry; H C Neu; M Merlino; P F Gaerlan; C N Ores; C R Denning
Journal: J Pediatr Date: 1977-01 Impact factor: 4.406

7. Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Authors: W K Lau; L S Young; A B Osher; R R Dooley
Journal: Pediatrics Date: 1977-09 Impact factor: 7.124

8. PRODUCTION OF ELASTASE AND PROTEINASE BY PSEUDOMONAS AERUGINOSA.

Authors: K MORIHARA
Journal: J Bacteriol Date: 1964-09 Impact factor: 3.490

9. Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages.

Authors: M Pollack; S E Anderson
Journal: Infect Immun Date: 1978-03 Impact factor: 3.441

10. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

Authors: P H Beaudry; M I Marks; D McDougall; K Desmond; R Rangel
Journal: J Pediatr Date: 1980-07 Impact factor: 4.406

14 in total

Review 1. Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors: R Wilson; R B Dowling
Journal: Thorax Date: 1998-03 Impact factor: 9.139

2. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.

Authors: Sally Palser; Sherie Smith; Edward F Nash; Arnav Agarwal; Alan R Smyth
Journal: Cochrane Database Syst Rev Date: 2019-12-17

3. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study.

Authors: K A Miszkiel; A U Wells; M B Rubens; P J Cole; D M Hansell
Journal: Thorax Date: 1997-03 Impact factor: 9.139

Review 4. Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa.

Authors: H L Rocchetta; L L Burrows; J S Lam
Journal: Microbiol Mol Biol Rev Date: 1999-09 Impact factor: 11.056

5. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro.

Authors: K Kanthakumar; G Taylor; K W Tsang; D R Cundell; A Rutman; S Smith; P K Jeffery; P J Cole; R Wilson
Journal: Infect Immun Date: 1993-07 Impact factor: 3.441

6. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.

Authors: R F Taylor; M E Hodson; T L Pitt
Journal: Thorax Date: 1993-10 Impact factor: 9.139

7. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.

Authors: U Sajjan; J Reisman; P Doig; R T Irvin; G Forstner; J Forstner
Journal: J Clin Invest Date: 1992-02 Impact factor: 14.808

8. Fecal isolation of Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors: U Agnarsson; S Glass; J R Govan
Journal: J Clin Microbiol Date: 1989-01 Impact factor: 5.948

9. Antigen-antibody interactions: elucidation of the epitope and strain-specificity of a monoclonal antibody directed against the pilin protein adherence binding domain of Pseudomonas aeruginosa strain K.

Authors: W Y Wong; R T Irvin; W Paranchych; R S Hodges
Journal: Protein Sci Date: 1992-10 Impact factor: 6.725

10. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection.

Authors: Brian J Day; Anna M van Heeckeren; Elysia Min; Leonard W Velsor
Journal: Infect Immun Date: 2004-04 Impact factor: 3.441